Beau's Lines and COVID-19; A Systematic Review on Their Association.
Agouridis AP, Mastori-Kourmpani C, Antoniou P, Konstantinou P, Rizos EC, Tsioutis C.
Pathogens. 2024 Mar 20;13(3):265. doi: 10.3390/pathogens13030265.
Beau's Lines and Onychomadesis: A Systematic Review of Characteristics and Aetiology.
Kim BR, Yu DA, Lee SR, Lim SS, Mun JH.
Acta Derm Venereol. 2023 Oct 30;103:adv18251. doi: 10.2340/actadv.v103.18251.
Beau's lines.
Jandial A, Mishra K, Prakash G, Malhotra P.
BMJ Case Rep. 2018 Mar 28;2018:bcr2018224978. doi: 10.1136/bcr-2018-224978.
Beau's lines.
Lin X, Wu S.
QJM. 2017 Oct 1;110(10):669-670. doi: 10.1093/qjmed/hcx122.
Beau lines, onychomadesis, and retronychia: A unifying hypothesis.
Braswell MA, Daniel CR 3rd, Brodell RT.
J Am Acad Dermatol. 2015 Nov;73(5):849-55. doi: 10.1016/j.jaad.2015.08.003.
Beau's Lines Associated With IVIG Infusions.
Conway J, Lipner SR.
J Cutan Med Surg. 2023 Mar-Apr;27(2):180. doi: 10.1177/12034754221147285. Epub 2023 Jan 13.
Beau's lines.
Singhal M, Bakhshi S.
J Assoc Physicians India. 2011 Apr;59:248.
Beau's lines.
Chang CC, Wu CC.
QJM. 2013 Apr;106(4):383. doi: 10.1093/qjmed/hcs050. Epub 2012 Mar 8.
Multiple Beau Lines and Onychomadesis.
Chen TL, Chen CC.
Mayo Clin Proc. 2023 Nov;98(11):1727-1728. doi: 10.1016/j.mayocp.2023.06.006.
Beau lines associated with COVID-19.
Alobaida S, Lam JM.
CMAJ. 2020 Sep 8;192(36):E1040. doi: 10.1503/cmaj.201619.
